Larimar Therapeutics Inc.
LRMR | NASDAQ
$3.83
+$0.04 (+1.06%)
At close: Sep 21, 2026, 4:00 PM ET
$3.83
$0 (0.00%)
Pre-market:
Sep 22, 2026, 7:00 AM ET
Market Data
Market Cap $397.87M
Enterprise Value $246.56M
Beta 0.75
Average Volume 1.84M
Shares Outstanding (Diluted) 103.88M
Shares Change YoY 62.25%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US5171251003
Price Performance
Price Change 1M -8.8%
Price Change 3M 4.1%
Price Change 6M -18.2%
Price Change YTD 10.4%
Price Change 1Y -14.5%
Price Change 3Y -8.8%
Price Change 5Y -69.2%
1M CAGR (ann.) -7.9%
1Y CAGR (ann.) -10.5%
5Y CAGR (ann.) -21.8%
All-Time CAGR -28.6%
Valuation
PE Ratio -1.92
Forward PE N/A
PEG Ratio 0.07
Forward PEG 0.13
PS Ratio N/A
Forward PS 9.50
PB Ratio 3.12
P/FCF Ratio -2.55
P/Adj. FCF Ratio -2.43
P/OCF Ratio -2.55
EV/Sales N/A
EV/EBIT -1.43
EV/EBITDA -1.43
EV/FCF -1.58
Earnings Yield -52.0%
FCF Yield -39.2%
Adj. FCF Yield -41.1%
Financial Health
Net Cash $156.27M
Total Debt $4.96M
Cash & Short-Term Investments $156.27M
Total Assets $165.3M
Current Ratio 4.70
Quick Ratio 4.70
Debt / Equity Ratio 0.04
Debt / EBITDA -0.03
Debt / FCF -0.03
OCF / Debt -31.46
Interest Coverage 0.00
Altman Z-Score -0.44
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -4.8%
Returns
Return on Assets -104.4%
Return on Equity -137.4%
Return on Invested Capital -135.3%
Return on Capital Employed -136.5%
Return on Tangible Assets -104.4%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -27.9%
EPS CAGR 5Y 1.6%
EPS CAGR 10Y 32.0%
FCF CAGR 3Y -57.9%
FCF CAGR 5Y -43.1%
FCF CAGR 10Y -24.6%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 8
EPS Growth Next 3Y 42.0%
Revenue Growth Next 3Y N/A
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.39
EPS Growth Est (next Q) -36.1%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $8
Price Target Upside 108.9%
Cash Flow
Operating Cash Flow $-155.92M
Free Cash Flow $-156.08M
Adj. Free Cash Flow $-163.55M
FCF Per Share -$1.50
OCF Per Share -$1.50
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-178.99M
EBITDA $-172.3M
Net Income $-172.61M
EPS (Diluted) -$1.99
Revenue / Employee N/A
Profit / Employee $-2.43M
Employees 71
Add to Watchlist
Select watchlists to add or remove LRMR